Entry Detail



General Information

Database ID:exR0080586
RNA Name:RPL23
RNA Type:mRNA
Chromosome:chr17
Starnd:-
Coordinate:
Start Site(bp):38847860End Site(bp):38853764
External Links:ENSG00000125691



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC245033.1
chr15
82536788
82573194
-
AC007192.1
chr19
18153158
18178117
+
ACSL4
chrX
109624244
109733403
-
ADAMTS1
chr21
26835755
26845409
-
AHCY
chr20
34280268
34311802
-
AK3
chr9
4709556
4742043
-
AL928654.3
chr14
105487199
105492267
+
AL139300.1
chr14
103562962
103685924
+
ALDOA
chr16
30064164
30070457
+
ACTR2
chr2
65227753
65271253
+
AC018512.1
chr15
43772617
43799133
-
ADPGK
chr15
72751369
72785846
-
ACTG1
chr17
81509971
81523847
-
AKR1B1
chr7
134442356
134459284
-
AC068234.1
chr17
47253897
47344292
+
AC010422.3
chr19
12643831
12648397
-
AC073896.1
chr12
56285916
56316059
-
AL713999.1
chr1
155169409
155187272
-
AC040162.1
chr16
67929614
67936017
-
ACIN1
chr14
23058564
23095614
-
ACACA
chr17
37084992
37406836
-
ACTB
chr7
5527148
5563784
-
ADAM23
chr2
206443532
206621127
+
AL121758.1
chr20
646626
675800
-
AC124312.1
chr15
24955034
25000276
+
AC120057.2
chr17
7240427
7244635
-
ACO1
chr9
32384603
32454769
+
ACTA1
chr1
229431245
229434098
-
ALDH7A1
chr5
126531200
126595362
-
ADD3
chr10
109996368
110135565
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-4724-3p
chr17
31534941
31534961
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005062.1
chr7
19918981
20140453
-
AC005614.2
chr19
40048757
40090925
-
AC007952.4
chr17
19112000
19112636
-
AC009055.2
chr16
65190973
65234914
-
AC016876.2
chr17
7581964
7584086
-
AC023509.1
chr12
53441741
53467528
+
AC090204.1
chr8
32927913
33045445
+
AC091564.7
chr11
6610883
6616594
-
AC092490.1
chr12
8788253
8795789
+
AC120114.2
chr16
29862760
29863417
+
AC132217.1
chr11
2129121
2129964
-
AC135048.1
chr16
30948386
30956511
+
AC245033.4
chr15
82533175
82540008
-
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
AL117332.1
chr20
21302731
21303704
-
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA